Showing results (111-120 of 361) with videos related to
Sort By:
Pageof 37
Journal of Proteome Research|January 11, 2011
Novel glycan biomarkers for the detection of lung cancerJames N Arnold, Radka Saldova, Marie C Galligan, et al.Plos One|February 23, 2010
Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cellsElizabeth R Smith, Kathy Qi Cai, Jennifer L Smedberg, et al.Annals of Obstetrics and Gynecology|March 27, 2025
Translational Implications of The Gut Microbiome in Women with A Benign or Malignant Pelvic MassPriya Sabu, Harsh B Pathak, Emily Nissen, et al.Oncotarget|August 26, 2015
Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomicsSarah Munchel, Yen Hoang, Yue Zhao, et al.Cancers|October 28, 2023
Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing SarcomaSoumya M Turaga, Vikalp Vishwakarma, Stacey L Hembruff, et al.Molecular Carcinogenesis|November 25, 2014
PTN signaling: Components and mechanistic insights in human ovarian cancerGeetika Sethi, Youngjoo Kwon, Rebecca J Burkhalter, et al.Developmental Biology|September 16, 2005
Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cellsCallinice D Capo-Chichi, Malgorzata E Rula, Jennifer L Smedberg, et al.Journal of the National Cancer Institute|October 13, 2009
Prospective case-control study of serum mullerian inhibiting substance and breast cancer riskJoanne F Dorgan, Frank Z Stanczyk, Brian L Egleston, et al.Molecular Cancer Therapeutics|August 27, 2003
Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumorsAndrey Frolov, Santiago Chahwan, Michael Ochs, et al.Fertility and Sterility|June 28, 2011
Serum antimüllerian hormone in healthy premenopausal womenChristiana M Shaw, Frank Z Stanczyk, Brian L Egleston, et al.Pageof 37